This inventor holds 1 USPTO granted patent. Top assignee: Amersham Plc. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Shirley Elizabeth Pullan
Introduction
Shirley Elizabeth Pullan is a notable inventor based in Amersham, GB. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative work on bisphosphonates. His research focuses on enhancing the effectiveness of cancer treatments by utilizing radiolabelled compounds.
Latest Patents
Shirley Pullan holds a patent for "Radiolabelled bisphosphonates and method." This invention relates to P or P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The P- or P-labelled bisphosphonates are chemically identical to the unlabelled agent and are expected to target the lesion site in an identical manner. Additionally, they deliver a significant radiocytotoxic effect to the surrounding cells. This innovative approach aims to reduce the proliferative capacity of cells associated with tumor lesions, leveraging the favorable energetics of the β particle emission from the P nuclide. The relative stability and in vivo localization of bisphosphonates make them excellent candidates as P/P delivery vehicles. He has 1 patent to his name.
Career Highlights
Shirley Pullan has had a distinguished career, working with Amersham Plc, a company known for its advancements in medical imaging and radiopharmaceuticals. His work has contributed to the development of innovative treatments that improve patient outcomes in oncology.
Collaborations
Throughout his career, Shirley has collaborated with notable colleagues, including Alexander Mark Gibson and Marivi Mendizabal. These partnerships have fostered a collaborative environment that enhances research and development in the field of radiopharmaceuticals.
Conclusion
Shirley Elizabeth Pullan's contributions to the field of radiopharmaceuticals through his innovative patent on bisphosphonates highlight his commitment to advancing cancer treatment. His work continues to influence the development of effective therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile